HUS ParisMode de compatibilité]

First Page		Document Content
Date: 2016-05-16 12:27:10 Complement system Blood disorders Eculizumab Immunosuppressants Acquired hemolytic anemia Atypical hemolytic uremic syndrome Thrombotic microangiopathy TMA C5-convertase Nephrology Dialysis Factor H		HUS ParisMode de compatibilité] Add to Reading List Source URL: www.hemapherese.fr Download Document from Source Website File Size: 3,19 MB Share Document on Facebook

	IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic DocID: 1pS8s - View Document
	Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris DocID: 1pPKn - View Document
	HUS ParisMode de compatibilité] DocID: 1oXIv - View Document
	Complement, thrombotic microangiopathy and disseminated intravascular coagulation DocID: 1bMSQ - View Document
	Supplement Table S3. Drugs and other substances reported to be associated with thrombotic microangiopathy SUBSTANCE CITATION YEAR DocID: 1b0Bp - View Document